Pear Therapeutics Inc. Warrant (PEARW)
$0.01
$0.00
(31.11%)
As on 18-Apr-2023 15:37EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pear Therapeutics Inc. Warrant (PEARW)
| -96.0 | -93.9 | -95.1 | -99.2 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Pear Therapeutics Inc. Warrant (PEARW)
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products... include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts. Read more
-
Founder, Pres, CEO & Director
Dr. Corey M. McCann M.D., Ph.D.
-
Founder, Pres, CEO & Director
Dr. Corey M. McCann M.D., Ph.D.
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Pear Therapeutics Inc. Warrant (PEARW)
What is the current share price of Pear Therapeutics Inc Warrant (PEARW) Today?
The share price of Pear Therapeutics Inc Warrant (PEARW) is $0.01 (NASDAQ) as of 18-Apr-2023 15:37 EDT. Pear Therapeutics Inc Warrant (PEARW) has given a return of -99.16% in the last 1 years.
What is the current PB & PE ratio of Pear Therapeutics Inc Warrant (PEARW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-871.55 |
676.50 |
2021 |
-4,044.24 |
914.76 |
2022 |
-871.55 |
676.50 |
2021 |
-4,044.24 |
914.76 |
What is the 52 Week High and Low of Pear Therapeutics Inc Warrant (PEARW)?
The 52-week high and low of Pear Therapeutics Inc Warrant (PEARW) are Rs -- and Rs -- as of 05-Sep-2026.
What is the market cap of Pear Therapeutics Inc Warrant (PEARW)?
Pear Therapeutics Inc Warrant (PEARW) has a market capitalisation of -- as on 18-Apr-2023. As per SEBI classification, it is a company.
Should I invest in Pear Therapeutics Inc Warrant (PEARW)?
Before investing in Pear Therapeutics Inc Warrant (PEARW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.